Valeant’s third-quarter results provided a welcome dose of good news as the company works to execute its lengthy turnaround. Point one: It’s paid off $6 billion of its monstrous debt load. But point two? Sales were down 10%, despite growth at Bausch & Lomb.
More: Valeant investors cheer turnaround effort after Q3 results, but can it stick?